
ML406
CAS No. 774589-47-8
ML406( ML406 | ML-406 | ML 406 )
Catalog No. M15926 CAS No. 774589-47-8
ML406 is a small molecule Mtb bioA (DAPA synthase) enzyme inhibitor (IC50=30 nM) that shows anti-tubercular activity.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 65 | Get Quote |
![]() ![]() |
10MG | 110 | Get Quote |
![]() ![]() |
25MG | 222 | Get Quote |
![]() ![]() |
50MG | 368 | Get Quote |
![]() ![]() |
100MG | 536 | Get Quote |
![]() ![]() |
500MG | 1161 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameML406
-
NoteResearch use only, not for human use.
-
Brief DescriptionML406 is a small molecule Mtb bioA (DAPA synthase) enzyme inhibitor (IC50=30 nM) that shows anti-tubercular activity.
-
DescriptionML406 is a small molecule Mtb bioA (DAPA synthase) enzyme inhibitor (IC50=30 nM) that shows anti-tubercular activity, dispalys >100-fold selectivity over bioD; exhibits WT M. tb (H37Rv) growth inhibition without biotin with an IC50 of 3.2 uM.
-
In VitroML406 inhibits WT Mycobacterium tuberculosis (Mtb) (H37Rv) growth inhibition with the IC50 of 3.2 μM. BioA is an enzyme involved in biotin biosynthesis in Mtb that may serve as lead compounds for drug development for tuberculosis (TB).
-
In Vivo——
-
SynonymsML406 | ML-406 | ML 406
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number774589-47-8
-
Formula Weight352.39
-
Molecular FormulaC20H20N2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (283.78 mM)
-
SMILESCC(C1=CC=C(N2CCN(C(C3=CC=C(OCO4)C4=C3)=O)CC2)C=C1)=O
-
Chemical Name1-(4-(4-(Benzo[d][1,3]dioxole-5-carbonyl)piperazin-1-yl)phenyl)ethanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Casalena D, et al. Probe Reports from the NIH Molecular Libraries Program [Internet].
molnova catalog



related products
-
I-2906
A novel isocitrate lyase (ICL) inhibitor that displays showed excellent anti-Mycobacterium tuberculosisl activities and low cytotoxicity.
-
Sarafloxacin
Sarafloxacin has antibacterial activities against Gram-positive and Gram-negative bacteria.
-
Doripenem
Doripenem is a new parenteral carbapenem antibiotic with broad-spectrum activity against gram-negative and gram-positive pathogens.